Hypnotic Benzodiazepines

Spectrum of pharmacological effects

Benzodiazepine derivatives exhibit a wide spectrum of activity depending on the dosage and site of action. The main pharmacological effects include:

• Anxiolytic (anti-anxiety): the drugs effectively eliminate fear, internal anxiety, and severe mental tension. It is the relief of emotional tension that promotes general sedation and creates a favorable background for the onset of physiological sleep.
• Sedative and hypnotic: relatively low doses produce a calming effect, which transitions into a full hypnotic effect with a systematic increase in dose.
• Myorelaxant: a decrease in pathologically elevated skeletal muscle tone is observed. This process is due to the direct inhibition of nerve impulse transmission in polysynaptic reflex arcs at the spinal cord level.
• Anticonvulsant: benzodiazepines are capable of suppressing pathological seizure activity in the brain.
• Amnestic: a specific property of the drugs is the ability to cause anterograde amnesia, in which the patient temporarily loses memory of events occurring immediately after administration of the medication.

Localization of action in the nervous system

Pharmacodynamic effects are achieved through targeted inhibition of the activity of specific anatomical structures of the central nervous system. The hypnotic and anti-anxiety effects are primarily associated with an effect on the limbic system, which is responsible for the formation and regulation of human emotions.

Additionally, the drugs affect the reticular formation of the brainstem. Normally, this structure is an ascending activating system that maintains the cerebral cortex in an active state. Benzodiazepines reduce this ascending stimulatory influence, which inevitably leads to the suppression of cortical activity and facilitates falling asleep.

Receptors and the GABA-benzodiazepine complex

The key target for this group of drugs is specific benzodiazepine receptors (often designated in specialized literature as $\omega$-receptors). Several subtypes of these receptors are distinguished: $\omega_1$, $\omega_2$, and $\omega_3$. It is important to emphasize that the development of the hypnotic effect is strongly associated with the preferential activation of $\omega_1$-receptors.

These receptors do not exist in isolation, but are a structural and functional part of the complex GABA-A ($GABA_A$) receptor complex.

The structure of the complex is as follows:

1. The GABA-A receptor itself is a large glycoprotein that forms an ionic chloride channel within the cell membrane.
2. In terms of subunit composition, it is a pentamer (consisting of five parts): two $\alpha$-subunits, two $\beta$-subunits, and one $\gamma$-subunit.
3. The binding topography is strictly distributed: the endogenous inhibitory neurotransmitter GABA binds to the $\alpha$- and $\beta$-subunits, whereas benzodiazepine molecules bind exclusively to the $\gamma$-subunit.

Molecular mechanism: from binding to inhibition

At the molecular and electrophysiological levels, the interaction of benzodiazepines with the receptor occurs through allosteric modulation. When a drug binds to its $\gamma$-subunit, it significantly increases the sensitivity of the entire complex to the neurotransmitter (GABA). As a result, the effectiveness of natural endogenous GABA increases manifold.

The most important difference of benzodiazepines is that their intrinsic activity does not increase: they are unable to independently open the ion channel without the presence of GABA. This explains the absence of a direct narcotic effect, which is characteristic of substances capable of opening chloride channels directly, without the participation of a neurotransmitter.

Electrophysiological result:

• The frequency of chloride channel opening increases.
• A massive influx of negatively charged chloride ions ($Cl^-$) into the neuron occurs.
• A profound hyperpolarization of the neuronal membrane develops.
• The result is the development of powerful inhibitory processes in the CNS.

It should also be remembered that benzodiazepines enter into pharmacodynamic interactions with other substances. In particular, there is a potentiation (enhancement) of the action of any CNS depressants, including ethanol and general anesthetics.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Structural differences between omega receptor subtypes ($\omega_1$, $\omega_2$, $\omega_3$)
• Detailed structure of the GABA-A receptor and functions of its subunits
• Mechanism of development of anterograde amnesia
• Spinal mechanisms of polysynaptic reflex inhibition

Other topics in the section "Agents Used in Psychiatry and Neurology"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.